Chamber and committees

In determining an application for a marine licence (under the Marine (Scotland) Act 2010 and Marine and Coastal Access Act 2009) the Scottish Ministers must have regard to protection of the environment and human health, prevention of interference with legitimate uses of the sea and such other matters as the Scottish Ministers consider relevant. Marine licences do not include conditions in relation to Fair Work First criteria and commitments to supporting domestic supply chains. Such conditions cannot be applied to s.36 consents issued under the Electricity Act 1989 for the construction, operation or extension of generating stations either.

ScotWind applicants were required to submit a Supply Chain Development Statement (SCDS) setting out the anticipated level and location of supply chain impact for their projects. We have now seen these statements yield commitments by developers to invest an average projection of £1.5bn in Scotland across each of the 17 ScotWind offshore wind projects. Developers can update their Statements throughout the development phase. Failure to deliver the commitments laid out in the final SCDS can trigger remedies ranging from financial penalties to an inability to progress to seabed lease.

The Scottish Government has not held discussions with Cerulean Winds nor NOV Inc as they do not have consented developments under construction. It is therefore premature to discuss contracts for projects which do not yet exist. Developers will be required to submit a Supply Chain Development Statement with bids for the Innovation and Targeted Oil and Gas decarbonisation (INTOG) leasing rounds when it opens this year. Similarly to ScotWind, developers will need to outline the supply chain activity they commit to undertaking within Scotland, the UK and overseas.

The Scottish Government is focussed on delivering the commitments set out in our NHS Recovery Plan, published in August 2021.

With regard to cataracts, the Scottish Government is working with Health Boards to undertake additional pre-assessment clinics to assess those patients referred for consideration of surgery. In tandem, Boards are implementing new and more efficient ways of working, including virtual appointments and via telephone to prevent unnecessary visits and travel to hospitals.

The independent sector is also supporting additional cataract surgeries across a number of Health Board areas. In particular, over 3,500 additional surgeries were undertaken by the Independent Sector at NHS Golden Jubilee (NHSGJ) in 21-22, and will continue to deliver an additional 1,000 surgeries in 22-23. Plans are also in place to enable a number of Boards to utilise available capacity at NHSGJ using their own surgeons, who will undertake cataract surgery at the facility. This will allow patients access to treatment more quickly, as well as offering opportunities for training junior surgeons.

The Centre of Sustainable Delivery has been commissioned to support surgical teams across NHSScotland to implement the guidance issued by the Royal College of Ophthalmologists. This will increase efficiency and productivity across cataract-only surgical sessions, and high-volume surgery in cataract treatment centres.

We are working closely with Boards to finalise planned care activity plans, including for orthopaedics, for 2022-23 which will be critical to stabilising and improving our health and social care system in the medium term.

The National Treatment Centre (NTC) Programme will deliver the single biggest increase in protected planned care capacity ever created in NHS Scotland. The network of 10 NTCs, will deliver capacity for over 40,000 additional planned procedures and diagnostic care across 12 specialities. Within the next 18 months, NTCs will open in NHS Fife, NHS Forth Valley, NHS Highland and at NHS Golden Jubilee specialising in orthopaedic surgery. On 13 April, we also announced £1.8m of funding to purchase a private hospital in Ayrshire (Carrick Glen) to be developed into a new National Treatment Centre specialising in orthopaedics.

As well as significant investment in new infrastructure, the new NHSScotland Centre for Sustainable Delivery is also leading work to explore new and innovative ideas to reduce In Patient / Day Case and Outpatient waiting times. Examples include:

• The rollout of Active Clinical Referral Triage, to provide patients with information about non-surgical interventions and self-management options;
• Patient Initiated Reviews, enabling patients to be escalated if their condition deteriorates and reduces routine appointments while supporting patients in a safe and clinically appropriate manner; and
• Enhanced Recovery after Surgery pathways, designed to support patients achieve faster recovery after surgery.

Public Health Scotland (PHS) uses the national waiting times warehouse to collect electronic patient records covering the waits that patients experience waiting for a new outpatient appointment. This data source can be used routinely to identify the specialty of treatment, such as whether the patient was waiting for an appointment in ophthalmology or orthopaedics. However, it is not possible to ascertain whether the appointment involved an assessment of whether the patient is suitable for a particular procedure. This level of information may be held locally by NHS Boards.

Statistics relating to the waits patients experience for new outpatient appointments, at specialty and NHS Board level, are published up to 31 December 2021 and can be found using the following link:

https://www.publichealthscotland.scot/media/11694/newop_feb22.xlsx .

Before we made the decision to lift remaining legal measures and close the Highest Risk list, we and our clinical advisers carefully considered the impact on people who are immunosuppressed or immunocompromised. There is strong evidence to show that the vaccine is offering significant protection and preventing the majority of people whose immune systems are suppressed or compromised from becoming severely ill if they are infected with COVID-19.

We know that the degree of protection offered by the vaccines wanes over time, which is why booster vaccinations are needed to maintain the best protection against COVID-19 for those at highest risk of the severe effects of the virus. Second booster appointments for people with suppressed immune systems have already started.

However, we are also aware that for some of this group, it is not possible to mount a full immune response due to their medication, treatment or health condition.

Many immunosuppressed or immunocompromised individuals lived with and managed the risk posed by other diseases and infections before the COVID-19 pandemic, and will continue to be advised by their GP and specialist clinical team, who best know their individual circumstances, on how to reduce their risk of infection from both COVID-19 and other viruses. We’ve also made new treatments available to those who are eligible for them who will benefit the most – including some people who are immunocompromised or immunosuppressed .

The Scottish Government is determined to maximise the economic opportunity for the Scottish supply chain from our offshore wind potential.

We will drive forward offshore wind skills development – working with stakeholders to focus on the opportunities for diversification and skills transfer from our oil and gas sector, in line with our commitment to a Just Transition.

The introduction of ScotWind’s Supply Chain Development Statements demonstrates how serious the Scottish Government is about holding developers to account if they do not honour their supply chain commitments and create green jobs .

Anyone, of any age, who displays signs or symptoms of breast cancer should report concerns to their GP. Should further investigation be required, which can include a lump in breast tissue, this would be referred through the symptomatic service, and not directed to the Scottish Breast Screening Programme. There are no plans to change this.

The UK National Screening Committee, an independent scientific body that advises all four UK nations on screening, currently recommends that women between the ages of 50 and 70 are invited for three yearly routine breast screening because there is clear evidence of benefit from screening women of that age group. The UK NSC does not recommend that women over 71 are invited for breast screening.

While programme capacity remains challenging due to COVID-19, there remains a pause on self-referrals for those over the age of 71 in order to allow appointments to be prioritised for the recommended screening population. However, in recognition of the anxiety that the pause on self-referrals is causing, work is underway with the National Screening Oversight and the Scottish Breast Screening Programme Board to explore ways to restart the self-referral route by Autumn 2022, in a way that does not unduly impact on screening of the eligible cohort, and with a number of factors being worked through.

We continue to emphasise that, regardless of their age, women should remain symptom aware and report any concerns to their GP immediately for these to be investigated and followed up as appropriate. The pause on the self-referral option has never altered this position.